Back to top
more

Avantor (AVTR)

(Delayed Data from NYSE)

$24.38 USD

24.38
5,696,340

-0.22 (-0.89%)

Updated Apr 17, 2024 04:00 PM ET

After-Market: $24.38 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

BLCO vs. AVTR: Which Stock Is the Better Value Option?

BLCO vs. AVTR: Which Stock Is the Better Value Option?

Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Three Reasons to Retain Avantor (AVTR) Stock in Your Portfolio

Avantor's (AVTR) strong product portfolio raises optimism about the stock.

BLCO or AVTR: Which Is the Better Value Stock Right Now?

BLCO vs. AVTR: Which Stock Is the Better Value Option?

Pediatrix Medical Group, Inc. (MD) Up 11% Since Last Earnings Report: Can It Continue?

Pediatrix Medical Group, Inc. (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BLCO or AVTR: Which Is the Better Value Stock Right Now?

BLCO vs. AVTR: Which Stock Is the Better Value Option?

New Strong Sell Stocks for February 20th

HAFC, AVTR and WHD have been added to the Zacks Rank #5 (Strong Sell) List on February 20, 2024.

Avantor (AVTR) Q4 Earnings & Revenues Top Estimates, Margins Down

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft fourth-quarter performance.

Compared to Estimates, Avantor, Inc. (AVTR) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Curious about Avantor, Inc. (AVTR) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Avantor, Inc. (AVTR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.

ELV vs. AVTR: Which Stock Is the Better Value Option?

ELV vs. AVTR: Which Stock Is the Better Value Option?

Viatris (VTRS) Up 5.1% Since Last Earnings Report: Can It Continue?

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite

Avantor's (AVTR) latest offerings are likely to provide its customers with products, materials and services that would aid in accelerating therapeutics.

Avantor (AVTR) Q3 Earnings In-Line With Estimates, Revenues Top

Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft third-quarter performance.

Compared to Estimates, Avantor, Inc. (AVTR) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Avantor, Inc. (AVTR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Avantor, Inc. (AVTR) Q3 Earnings Meet Estimates

Avantor, Inc. (AVTR) delivered earnings and revenue surprises of 0% and 1.22%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for

Avantor, Inc. (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Revvity's (RVTY) New Launch to Widen Access to Editing Technology

Revvity's (RVTY) latest offering is likely to improve access to new-generation editing technology and bridge both preclinical and clinical discoveries with the same technology platform.

Alignment Healthcare (ALHC) Soars 5.9%: Is Further Upside Left in the Stock?

Alignment Healthcare (ALHC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Avantor's (AVTR) Tie-Up to Address Temperature-Specific Logistics

Avantor's (AVTR) partnership is likely to meet the growing need among biopharma and life science companies for end-to-end solutions.

New Strong Sell Stocks for September 11th

AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.

Charles River (CRL) Down 6.1% Since Last Earnings Report: Can It Rebound?

Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Viatris (VTRS) Down 4.8% Since Last Earnings Report?

Viatris (VTRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Revvity (RVTY) Down 4.9% Since Last Earnings Report: Can It Rebound?

Revvity (RVTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for August 22nd

AVTR, BHLB and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2023.